ABOUT

Meet our Board of Directors

Experienced leaders providing strategic direction and oversight for Thryv Therapeutics as it develops next-generation precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.

Directors

Paul F. Truex, MBA
Chairman of the Board & Chief Executive Officer

Read biography →

Robert Booth, PhD
Director

Read biography →

Daniel Hétu, MD, MBA
Director

Read biography →

Melissa Koomey, MBA
Director

Read biography →

Jean-François Pariseau, MSc, MBA, ICD.D
Director

Read biography →

Amy Rudolph, PhD
Director

Read biography →

Marc-Olivier Sirard, CPA
Director

Read biography →

Observers

Youssef Bennani, PhD, MBA
Observer

Read biography →

Maxime Daigle, CPA
Observer

Read biography →

Sarah Williams, PhD
Observer

Read biography →

Scott Weiner, MBA
Observer

Read biography →